SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996???2003
7 references·2 citing·36 second hop
Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996???2003 (2006)Impacts of Cost Containment Strategies on…Taiwan’s New National Health Insurance Program: Genesis And Experience So Far (2003)Taiwan’s New National Health …Reference Pricing For Drugs: Is It Compatible With U.S. Health Care? (2003)Reference Pricing For Drugs: …European Healthcare Policies for Controlling Drug Expenditure (2003)European Healthcare Policies …Does Universal Health Insurance Make Health Care Unaffordable? Lessons From Taiwan (2003)Does Universal Health Insuran…Chapter 8 Moral hazard and consumer incentives in health care (2000)Chapter 8 Moral hazard and co…Taiwan's 1995 health care reform (1997)Taiwan's 1995 health care ref…Time Series Analysis: Forecasting and Control. (1978)Time Series Analysis: Forecas…Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2014)Pharmaceutical policies: effe…Performance impacts of interorganizational cooperation: a transaction cost perspective (2013)Performance impacts of intero…A Theory of the Allocation of Time (1965)Moral Hazard and Observability (1979)Health-Care Systems (2003)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries (2004)Unintended Consequences of Caps on Medicare Drug Benefits (2006)Industrial Society and Social Welfare (1958)National Health Insurance and precautionary saving: evidence from Taiwan (2002)Parental Education and Child Health: Evidence from a Natural Experiment in Taiwan (2009)Electoral Authoritarianism and Human Development (2015)Review of the literature on reference pricing (2000)Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (2003)Do generics offer significant savings to the UK National Health Service? (2006)Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand (2008)Measuring the efficiency of decision making units (1978)The Economic Institutions of Capitalism (1987)External Control of Organizations: Resource Dependence Perspective (2011)Payment Restrictions for Prescription Drugs under Medicaid (1987)Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)Pharmaceutical policies: effects of cap and co-payment on rational drug use (2008)The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm (2011)Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States (2014)INTERRUPTED TIME SERIES DESIGNS IN HEALTH TECHNOLOGY ASSESSMENT: LESSONS FROM TWO SYSTEMATIC REVIEWS OF BEHAVIOR CHANGE STRATEGIES (2003)Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2006)GRADE guidelines: 3. Rating the quality of evidence (2011)How OECD health systems define the range of good and services to be financed collectively (2016)Strategies to achieve fairer prices for generic and biosimilar medicines (2020)Horizontal equity in health care utilization evidence from three high-income Asian economies (2006)A 10-Year Experience with Universal Health Insurance in Taiwan: Measuring Changes in Health and Health Disparity (2008)Political and economic aspects of the transition to universal health coverage (2012)Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage (2008)Consolidating the social health insurance schemes in China: towards an equitable and efficient health system (2015)Principles of forecasting : a handbook for researchers and practitioners (2001)25 years of time series forecasting (2006)The politics of attention: how government prioritizes problems (2006)
this work references cited by second hop

References

  • 1978Time Series Analysis: Forecasting and Control.5,299 cited
  • 2003Taiwan’s New National Health Insurance Program: Genesis And Experience So Far696 cited
  • 2003Does Universal Health Insurance Make Health Care Unaffordable? Lessons From Taiwan529 cited
  • 2000Chapter 8 Moral hazard and consumer incentives in health care389 cited
  • 2003European Healthcare Policies for Controlling Drug Expenditure278 cited
  • 1997Taiwan's 1995 health care reform259 cited
  • 2003Reference Pricing For Drugs: Is It Compatible With U.S. Health Care?118 cited

Cited by

  • 2014Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies84 cited
  • 2013Performance impacts of interorganizational cooperation: a transaction cost perspective16 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work